Pregnancy Prevention Program Section of the Risk Management Plan for Soriatane® (acitretin): Survey to Assess Physician and Pharmacist Understanding of the Risk of Teratogenicity Associated with Soriatane First published 14/11/2017 Last updated 02/07/2024 EU PAS number:EUPAS21151 Study Finalised